Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
46 hedge funds and large institutions have $223M invested in Global Cord Blood Corporation in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 21 reducing their positions, and 14 closing their positions.
11% less capital invested
Capital invested by funds: $251M → $223M (-$28.1M)
21% less funds holding
Funds holding: 58 → 46 (-12)
40% less call options, than puts
Call options by funds: $535K | Put options by funds: $888K
43% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 21
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
79% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$2.31M |
| 2 |
Man Group
London,
United Kingdom
|
+$1.84M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$661K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$546K |
| 5 |
QOP
Quinn Opportunity Partners
Charlottesville,
Virginia
|
+$369K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.01M |
| 2 |
SAM
Silphium Asset Management
London,
United Kingdom
|
-$2.63M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.35M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.23M |
| 5 |
Lazard Asset Management
New York
|
-$1.17M |
CO Hedge Fund Activity: Q2 2018 in Review
46 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q2 2018, worth a combined $223M — down 11% from $251M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CO and 3 opened new positions — a net loss of 11 holders — while 21 trimmed existing stakes and 12 added.
The largest buyer was Norges Bank, adding an estimated $2.31M. The largest seller was Arrowstreet Capital, cutting an estimated $4.01M.
- 46 institutional investors held Global Cord Blood Corporation (CO) as of Q2 2018, down from 58 in Q1 2018.
- Funds reported $223M of Global Cord Blood Corporation stock for Q2 2018, down 11% quarter-over-quarter.
- 3 funds opened new Global Cord Blood Corporation positions in Q2 2018 and 14 closed out, a net change of -11 holders.
- The largest Global Cord Blood Corporation buyer in Q2 2018 was Norges Bank, an estimated $2.31M added.
- The largest Global Cord Blood Corporation seller in Q2 2018 was Arrowstreet Capital, an estimated $4.01M sold.
Based on aggregated 13F filings for Q2 2018.